PK/PD Clinical Trial of YYD601 in Healthy Adult Male

• Status: Completed
• Trial end date: 2018-02-07
• Target enrollment: 0
• Participant gender: Male

Summary

A dose block-randomized, open-label, parallel clinical trial

• Phase: Phase 1
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Yooyoung Pharmaceutical Co., Ltd.; Yooyoung Pharmaceutical Co.,Ltd.
• Treatments: Esomeprazole

Criteria

Inclusion criteria:

• Healthy adult male above 19 years old when getting a screening test.

• Subjects who have over 50kg weight, included in the IBW± 20% range. [IBW(kg)={height(cm)-100}x0.9

• Subjects who haven't any congenital or chronic disease, and any other disease following the medical examination.

• Subjects who are confirmed as a participant by the serum test, hematologital test, blood chemistry tests, urine tests, and clinical laboratory test, 12-lead EKG etc following the characteristics aboht the IP within the 3 weeks before investogator products are administrated.

• Subjects who voluntarily decide to participated in this trial after comletely understand about this clinical trial.

Exclusion criteria

• Subjects who are judged not suitable to participated in this trial.

• Other specific exlusion criteria is identified in the protocol.